Ann: Mayne Pharma presentation at JP Morgan Healthcare Conference, page-9

I note you complimented the current board for savvy management. Remember the criticism for selling the manufacturing/research plant which raised about A$750M. Without the sale MYX would be done for. The mob that regularly offer short sighted sloppy comment based on their hormone level at the time are pretty quiet now. The sale was the best and only way out to free MYX into a company with a different marketing method that can combat the big Pharma players who own and control ALL of the market. AND GUESS WHAT - the marketing method didnt start with the new board - it started with the previous MD (who may have been incompetent but had this idea) which is now (and always was) central to the future of MYX.
In addition, accumulating the dermatology and womens health portfolios was also the brainchild of the previous MD. I'm not saying the management was good but a very good idea was developed. The current board are building on it and hopefully will make MYX a powerhouse reseller. If they insert themselves between the manufacturers/owners of the products (to give them some return) and usurp big Pharma who screw the drug manufacturers/owners AND the retail reseller THE manufacturers/owners will get more return and be able to sell their product more profitably.

I pointed this out in detail a few years ago. Nobody seemed to know what the system was that was being developed. I didnt either because management did explain. So I rang MYX and found out the details. Thats why I have stuck with them and I will make a lot of money for sticking around.

It took a long long time to work out the devastation of buying the generic portfolio years ago. A huge disaster. BUT most of the whingers thought it was great and jumped in at $2-00 and are very upset. They were mugs.....